发明名称 LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS
摘要 <p>This invention provides a method of treating a patient afflicted with a neurodegenerative disorder , e.g., Huntington 's disease (HD), comprising administering to the patient laquinimod as an add- on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and pridopidine for treating a patient afflicted with a neurodegenerative disorder , e.g. , HD. This invention also provides laquinimod for use as an add- on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder , e.g., HD. This invention further provides use of laquinimod and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder, e.g., HD.</p>
申请公布号 IN3219DEN2015(A) 申请公布日期 2015.10.02
申请号 IN2015DE03219 申请日期 2015.04.16
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 HAYDEN ,MICHAEL;BAR -ZOHAR, DAN
分类号 A61P25/00;A61P25/18;A61P25/28 主分类号 A61P25/00
代理机构 代理人
主权项
地址